Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 258 Lung Neoplasms 207 Adenocarcinoma of Lung 44 Small Cell Lung Carcinoma 31 Adenocarcinoma, Bronchiolo-Alveolar 23 Brain Neoplasms 17 Breast Neoplasms 14 Neoplasm Metastasis 12 Mesothelioma, Malignant 10 Radiation Injuries 8 Neoplasms 8 Prostatic Neoplasms 7 Melanoma 7 Thymoma 6 Squamous Cell Carcinoma of Head and Neck 6 NSCLC 6 Head and Neck Neoplasms 6 Drug-Related Side Effects and Adverse Reactions 6 Carcinoma, Renal Cell 6 Pancreatic Neoplasms 4 Esophageal Neoplasms 4 Advanced NSCLC 4 Urinary Bladder Neoplasms 3 Salivary Gland Neoplasms 3 Rectal Neoplasms 3 Kidney Neoplasms 3 Esthesioneuroblastoma, Olfactory 3 Colorectal Neoplasms 3 Carcinoma, Squamous Cell 3 Thyroid Neoplasms 2

Interventions

durvalumab 2 tremelimumab 1 ceralasertib 1 aflutinib 1 Radiotherapy 1 Pemetrexed 1 Gemcitabine 1 Cisplatin 1 Carboplatin 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Non Small Cell Lung Cancer NSCLC × Radiotherapy × Thoracic × Clear all

NCT06680050 2025-12-18

AUSTRAL

Mario Negri Institute for Pharmacological Research

Phase 2 Recruiting

Non Small Cell Lung Cancer NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡